retatrutide triple agonist glp-1 gip glucagon phase 2 obesity trial just changed the conversation around weight loss medication. This (GLP-1 + + glucagon) is still in 3 trials, but Phase data showed 24.2% body weight loss Frequency:6 month supply Collection_Minerals Kidney and Cardiovascular Effectiveness

retatrutide triple agonist glp-1 gip glucagon phase 2 obesity trial just changed the conversation around weight loss medication. This (GLP-1 + + glucagon) is still in 3 trials, but Phase data showed 24.2% body weight loss Frequency:6 month supply Collection_Minerals Kidney and Cardiovascular Effectiveness

Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 Diabetes | JACC

They can give guidance and support to make someone’s GLP-1 journey safe and effective

Collection_Minerals

Frequency:6 month supply

Its GLP-1 drug semaglutide failed to treat Alzheimer’s across two large trials